FILGOTINIB, A SELECTIVE JANUS KINASE 1 (JAK1) INHIBITOR, MODULATES DISEASE-ASSOCIATED CYTOKINES IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS

被引：0
|
作者：
Taylor, Peter C. [1 ]
Elboudwarej, Emon [2 ]
LI Wanying [2 ]
Hawtin, Rachael E. [2 ]
Liu, Jinfeng [2 ]
Mirza, Amer M. [2 ]
机构：
[1] Univ Oxford, Botnar Res Ctr, Oxford, England
[2] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.2510
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0133
引用
收藏
页码：736 / 736
页数：1
相关论文
共 50 条
  • [41] Successful treatment of rheumatoid arthritis-associated interstitial lung disease with filgotinib: A case report on janus kinase 1 inhibition
    Sunaga, Atsuhiko
    Inoue, Takuya
    RESPIROLOGY CASE REPORTS, 2024, 12 (09):
  • [42] Phase III trials of JAK1 selective inhibitors in rheumatoid arthritis
    Mysler, Eduardo
    Lizarraga, Ana
    RHEUMATOLOGY, 2021, 60 (SUPPL 2) : ii17 - ii23
  • [43] Early phase studies of JAK1 selective inhibitors in rheumatoid arthritis
    Avci, Ali Berkant
    Feist, Eugen
    Burmester, Gerd Ruediger
    RHEUMATOLOGY, 2021, 60 : II11 - II16
  • [44] Filgotinib (GLPG0634), an Oral JAK1 Selective Inhibitor Is Effective in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: Results from a Phase 2B Dose Ranging Study
    Westhovens, R.
    Alten, Rieke
    Pavlova, Dace
    Enriquez-Sosa, Favio
    Mazur, Minodora
    Greenwald, Maria
    Van der Aa, Annegret
    Vanhoutte, Frederic
    Tasset, Chantal
    Harrison, Pille
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [45] Influence of age and renal impairment on the steady state pharmacokinetics of filgotinib, a selective JAK1 inhibitor
    Namour, Florence
    Fagard, Liesbeth
    Van der Aa, Annegret
    Harrison, Pille
    Xin, Yan
    Tasset, Chantal
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (12) : 2779 - 2789
  • [46] Identification of TUL01101: A Novel Potent and Selective JAK1 Inhibitor for the Treatment of Rheumatoid Arthritis
    Zhou, Shuhao
    Mao, Weiwei
    Su, Yuan
    Zheng, Xuejian
    Qian, Wenyuan
    Shen, Meiyue
    Shan, Ningli
    Li, Yaoshuang
    Wang, Degang
    Wu, Shouting
    Sun, Tiemin
    Mu, Liwei
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (24) : 16716 - 16740
  • [47] Discovery of the JAK1 selective kinase inhibitor AZD4205
    Kettle, Jason G.
    Su, Qibin
    Grimster, Neil
    Kawatkar, Sameer
    Throner, Scott
    Woessner, Richard
    Chen, Huawei
    Bebernitz, Geraldine
    Bell, Kristen
    Anderson, Erica
    Ruston, Linette
    Winter-Holt, Jon
    Lyne, Paul
    Vasbinder, Melissa
    Chuaqui, Claudio
    CANCER RESEARCH, 2017, 77
  • [48] Identification of CJ-15314, a Novel Highly Selective JAK1 Inhibitor, for the Treatment of Rheumatoid Arthritis
    Ki, So Young
    Kim, Dongkyu
    Lee, Juhyun
    Moon, Byoung Seok
    Ryu, Shin-Young
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [49] Discovery of the JAK1 selective kinase inhibitor AZD4205
    Su, Qibin
    Kettle, Jason
    Grimster, Neil
    Vasbinder, Melissa
    Kawatkar, Sameer
    Throner, Scott
    Woessner, Rich
    Chen, Huawei
    Chuaqui, Claudio
    Bebernitz, Geraldine
    Bell, Kristen
    Anderson, Erica Anderson
    Ruston, Linette
    Winter-Holt, Jon
    Yang, Wenzhan
    Lyne, Paul
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [50] Absence of Effects of Filgotinib on Erythrocytes, CD8+and NK Cells in Rheumatoid Arthritis Patients Brings Further Evidence for the JAK1 Selectivity of Filgotinib
    Galien, Rene
    Brys, Reginald
    Van der Aa, Annegret
    Harrison, Pille
    Tasset, Chantal
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
12345